In vitro activity of cysteamine against SARS-CoV-2 variants

Global COVID-19 pandemic is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Continuous emergence of new variants and their rapid spread are jeopardizing vaccine countermeasures to a significant extent. While currently available vaccines are effective at prevent...

Descripción completa

Detalles Bibliográficos
Autores principales: Thoene, Jess, Gavin, Robert F., Towne, Aaron, Wattay, Lauren, Ferrari, Maria Grazia, Navarrete, Jennifer, Pal, Ranajit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444157/
https://www.ncbi.nlm.nih.gov/pubmed/36115282
http://dx.doi.org/10.1016/j.ymgme.2022.08.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444157/
https://www.ncbi.nlm.nih.gov/pubmed/36115282
http://dx.doi.org/10.1016/j.ymgme.2022.08.009

Ejemplares similares